ArticleFrontiers in immunology2017

Toll-Like Receptor Ligand-Based Vaccine Adjuvants Require Intact MyD88 Signaling in Antigen-Presenting Cells for Germinal Center Formation and Antibody Production.

Munir M Mosaheb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.